866-945-0263 | enquiries@arrowheadpublishers.com

Join our Mailing List to Receive News, Information, Updates and Discounts on Upcoming Conferences, Reports and Webinars 

Subscribe

Conferences and Events

Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward.

Market Research Reports

Arrowhead Publishers is a leader in business intelligence and market research reports for the pharmaceutical and biotech industries. Our reports offer readers a blend of information, insight, analysis and forecasting that is essential in today’s ultra-competitive pharmaceutical and biotech markets. Our reports not only provide the most up-to-date market figures, forecasts, and pipeline data, but offer valuable analysis regarding successes and failures in the ever-competitive healthcare industry.

Event Planning Services

We can plan and execute your entire event or just consult with you on how to put it together, our services are flexible to suit your needs and budget. From curating speakers at the most highly regarded organizations in the world to defining a conference theme that will help your event to stand out from others, our years of experience in Life Science event planning will benefit your meeting, summit, symposium or conference.

Conference Calendar

  
 
The conference will once again bring together the top companies in the microbiome space working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products.

The meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will
have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head on to apply recent discoveries to a
variety of disease processes, restoration of health and improved outcomes.
 
Dates: April 21-23, 2020
Location: Boston, MA USA 
 

This conference brings together researchers and clinicians from industry, academia, the military and government to present ground-breaking research in a variety of areas related to traumatic brain injury.

This event provides a special opportunity for a variety of stakeholders to present original research and analysis aimed at providing a full picture of the progress being made towards better diagnosis, treatment and long-term care for TBI survivors. At this annual event, physicians, nurses, neurosurgeons, scientists, and drug/diagnostic developers from all over
the world network and learn from one another.
 
Dates: June 1-2, 2020
Location: Washington, DC
 

Join us at this virtual event, a dynamic learning environment for both academic and industry leaders to facilitate the growth of federated learning and establish the networks that will be vital to its development and promulgation. 
 
Dates: June 18-19, 2020
Location: Virtual
 

Join us in Washington, DC, where we will highlight the latest developments in the fields of drug repositioning, repurposing and rescue. This conference continues to serve as a global
meeting place for those engaged in efforts to further drug development through new means of collaborations, including patient advocacy efforts and industry/academic/government cooperation. 
 
Dates: September 21-22, 2020
Location: Washington, DC
 

Arrowhead's Annual Pain Therapeutics Summit is the US’s premier pain conference covering the field of pain research and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors.

This conference provides attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products.
 
Dates: September 21-22, 2020
Location: Washington, DC
 

Webinar: Expert Review of Recently Released FDA Analgesic Draft Guidance: Elucidation of Points Critical to Drug Developers

Date: April 23, 2014 (2 PM EST)

REGISTER

In February of 2014 the FDA released a draft guidance document related to the development of drugs for analgesic indications. A previous version of this document was released 22 years ago; during the George H.W. Bush era. Obviously much has changed. The importance of this document cannot be over emphasized in that it speaks to the current mindset of the FDA’s Division of Anesthesia, Analgesia, and Addiction Products (DAAAP). A multitude of topics are covered in it, including specific information regarding the following:

  • The development of new molecular entities versus reformulations
  • Requisite paths to specific analgesic indications
  • Early phase requirements
  • Appropriate endpoint selection
  • Recommended strategies for administration of rescue medication
  • Data imputation guidelines
  • Acceptable patient reported outcomes etc.

Many of the topics that drug developers have been guessing about for years are now to some degree spelled out. Of course every line is subject to interpretation, but the document is a great starting point. In this webinar, Dr. Singla will discuss the draft guidance document and highlight issues relevant to the analgesic drug development community.

ABOUT THE PRESENTER:

Dr. Neil Singla is the founder and Chief Scientific Officer for Lotus Clinical Research, an analgesic research site and CRO located in Pasadena California. Established in 2001 Lotus has: 40 employees, a 40 bed phase 1 unit, the ability to run phase 2/3 analgesic programs on a site and/or CRO level, full CRO capabilities and most importantly therapeutic expertise in pain.

Dr. Singla currently chairs the Analgesic Clinical Trials Special Interest Group at both the American Pain Society (APS) and the International Association for the Study of Pain (IASP). The main focus of Dr. Singla’s academic endeavors has been to analyze and understand how the inherent variability in analgesic clinical trials can be minimized. He has developed novel techniques for patient education designed to minimize variability, reduce placebo response and increase effect size. Dr. Singla’s affiliation with Lotus provides a unique opportunity not only to develop novel methodological techniques, but also implement and test them. Dr. Singla has frequent regulatory correspondence with the FDA's analgesics division on behalf of Lotus's pharmaceutical clients.

Contact Us

PO Box 96
Chanhassen, MN 55317 USA
866-945-0263
www.arrowheadpublishers.com
enquiries@arrowheadpublishers.com

Speaker Opportunities

If you are interested in speaking at one of Arrowhead's conferences or would like to suggest a conference theme for which you have particular expertise, we'd like to hear from you.

Sponsor/Exhibitor Opportunities

Arrowhead sponsorship and exhibitor levels are designed to give your organization the highest level of exposure and opportunity to market products and branding in an environment that is targeted toward facilitating professional networking. We can also build tailor-made packages that will meet your organization's marketing budget and goals. Arrowhead sponsorships are proven to help grow businesses through direct and targeted exposure to industry leaders and decision makers. To gain critical industry exposure via our sponsorship and exhibiting opportunities, please contact us.